Office of Public Relations – Newsroom
News Release
New Findings Mark Step Forward in Treatment of Cancer, Genetic Disease

Contact:  Kirsten Steinke

AURORA, Colo. (Oct. 31, 2006) – Researchers at the University of Colorado at Denver and Health Sciences Center have made an important stride in the future treatment of cancer and genetic disease. Their findings will be published in the Nov. 3 edition of Cell.

Mair Churchill, PhD, and Jessica Tyler, PhD, have developed a three-dimensional model of two of the protein building blocks of our chromosomes bound to another protein called Anti-Silencing Function 1 (Asf1).  Asf1 helps to make the DNA within our chromosomes accessible for gene regulation, genetic inheritance, and the repair of DNA damage. 

DNA, the molecule which encodes our genetic material, is tightly wound around histone proteins in the chromosomes. Asf1 makes this genetic material accessible by removing these proteins. The researchers discovered the precise way in which Asf1 binds to the histone proteins H3 and H4.

“This work provides the first molecular insight into how our cells gain access to DNA,” said Tyler, who has been studying the function of Asf1 for nearly ten years. “Cancer and genetic disease occur when genes which should be active become inactive. Because Asf1 helps to activate these genes, it may be a key to the treatment of these diseases.”

Asf1 cannot be seen by even the most advanced microscopes, and so the researchers worked to determine the shape of the protein by a method called X-ray crystallography. “This method uses proteins that have been crystallized and X-rays to decipher their detailed atomic structure,” said Churchill. “It gives a picture of where the atoms are in the proteins, and with that information we make interpretations about the function of the proteins.”

 “Understanding the shape of this protein complex helps us better understand its function and behavior,” said Tyler. “In doing so, we may learn to control this behavior and correct the chromosomal defects which cause cancer and genetic diseases, such as fragile X and cystic fibrosis.”

The School of Medicine faculty work to advance science and improve care as the physicians, educators and scientists at University of Colorado Hospital, The Children's Hospital, Denver Health, National Jewish Medical and Research Center and the Veterans Administration Medical Center.  The School is part of the University of Colorado at Denver and Health Sciences Center, one of three universities in the University of Colorado system.  For more information, visit the Web site at www.uchsc.edu or the UCDHSC Newsroom at http://www.uchsc.edu/news.